Fractyl Health Inc GUTS.OQ GUTS.O is expected to report resultson August 12 for the period ending June 30 2025
LSEG's mean analyst estimate for Fractyl Health Inc is for a loss of 36 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Fractyl Health Inc is $10.00, about 90.4% above its last closing price of $0.96
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.48
-0.48
-0.49
Missed
-2.8
Dec. 31 2025
-0.45
-0.43
-0.52
Missed
-19.5
Sep. 30 2024
-0.50
-0.50
-0.48
Beat
4
Jun. 30 2024
-0.46
-0.46
-0.36
Beat
21.7
Mar. 31 2024
-0.30
-0.30
-0.17
Beat
43.3
This summary was machine generated August 8 at 23:17 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)